Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 2Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1Thyroid Diseases 1Neoplasm Metastasis 1

Interventions

Radiosurgery 23Magnetic Resonance Spectroscopy 13Radiotherapy 9Cryosurgery 9Blood Specimen Collection 9Standard of Care 8Surveys and Questionnaires 7Educational Status 7Surgical Procedures, Operative 6Drug Therapy 6Radiotherapy, Intensity-Modulated 5Palliative Care 5Methods 5Radiofrequency Ablation 4Practice Guidelines as Topic 4Everolimus 4Early Intervention, Educational 4Interviews as Topic 3Exercise Therapy 3Cryotherapy 3Androgen Antagonists 3Zoledronic Acid 2Videotape Recording 2Trastuzumab 2Radiation 2Physical Therapy Modalities 2Patient Navigation 2Misoprostol 2Manual Lymphatic Drainage 2Liver Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoplasm Metastasis × AZD 6244 × Clear all
NCT00970359 2017-04-12

Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244

Memorial Sloan Kettering Cancer Center

Phase NA Completed
24 enrolled 8 charts
Head & Neck

Neoplasm Metastasis, Thyroid Diseases, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡